Summary

The bunion surgery market is expected to grow by USD 606.1 million in 2029 from USD 458.4 million in 2024 at a growth rate of 5.7% during the forecast period. Increasing numbers of bunion surgeries are the factor driving the growth of the bunion surgery market. With the continued increase in incidence of bunions, especially amongst the elderly population, the demands for surgical treatments to correct deformity increase. Additionally, increasing awareness of effective treatment alternatives and the availability of advanced techniques, including minimally invasive procedures, has increased the number of patients for bunion surgery.
“Hospitals segment is expected to have the fastest growth rate in the bunion surgery market, by end user, during the forecast period.”
Based on end user, the bunion surgery market is segmented into hospital, ambulatory surgery centers, and orthopedic clinics. The hospital segment is expected to have the highest CAGR during the forecasted period. The growth rate can be attributed to the availability of advance surgical techniques, and ongoing investment in healthcare infrastructure. As hospital continues to expand and adopt new and advance technologies they remain the preferred choice for complex bunion surgery.
“Minimally invasive surgeries segment accounted for the highest growth rate in the bunion surgery market, by type, during the forecast period.”
Based on type, the bunion surgery market is bifurcated into traditional surgeries and minimally invasive surgeries. The minimally invasive surgeries segment is expected to grow at the highest CAGR in the market of bunion surgery mainly due to advancement in technological such as specialized surgical tools. These surgeries have enhanced the precision and reliability of bunion surgery, making them more effective and accessible.

“Asia Pacific: The fastest-growing region in bunion surgery market.”
The global market for bunion surgery is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. Notably, the Asia-Pacific region marks the highest CAGR in the bunion surgery market, due to increasing investments into healthcare infrastructure. In addition to this, the number of rapidly aging patients strongly demands effective treatments for diseases related to age including bunion. The growing medical tourism activities in the APAC region also happen to be of great influence for the market, given the rapid increase of patients seeking advanced surgical treatments and high-class healthcare services. These factors, collectively, have put the APAC region on a growth trajectory for bunion surgery markets.
The break-up of the profile of primary participants in the bunion surgery market:
• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in the market are Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), CONMED Corporation (US), Zimmer Biomet (US), Treace Medical Concepts, Inc (US), Enovis Corporation (US), Medartis AG (Switzerland), Double Medical Technology Inc. (China), Arthrex, Inc. (US), Acumed LLC (US), Merete GmbH (Germany), BioPro, Inc. (US), Dieter Marquardt Medizintechnik GmbH (Germany), Exactech, Inc. (US), JEIL MEDICAL CORPORATION (South Korea), Ortimplant Orthopaedics & Medical Devices (Turkey), Astrolabe (Portugal), Extremity Medical (US), Voom Medical Devices (US), INVAMED (US), Auxein (India), Aysam Orthopaedics & Medical Devices (Turkey), and Deva Tıbbi Malzemeler (Turkey).
Research Coverage:
This research report categorizes the bunion surgery market by product (correction systems and implants & accessories), by patient type (adult patients and pediatric patients), by type (traditional surgeries and minimally invasive surgeries), by end user (hospitals, ambulatory surgery centers, and orthopedic clinics), and by region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the bunion surgery market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the bunion surgery market. Competitive analysis of upcoming startups in the bunion surgery market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bunion surgery market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (Increasing burden of bunion surgery, expanding geriatric population, rising incidence of sports injuries and rheumatoid arthritis, growing demand for minimally invasive surgery, increasing research funding and grants ), opportunities (rising number of hospitals and surgical centers worldwide, growth opportunities in emerging markets), restraints (high cost of surgery), and challenges (availability of non-surgical alternatives) influencing the growth of the bunion surgery market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the bunion surgery market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the bunion surgery market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bunion surgery market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), and Zimmer Biomet (US).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 25
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 26
1.4 CURRENCY CONSIDERED 27
1.5 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.2 RESEARCH APPROACH 28
2.2.1 SECONDARY DATA 29
2.2.1.1 Key data from secondary sources 29
2.2.2 PRIMARY DATA 30
2.2.2.1 Primary sources 31
2.2.2.2 Key data from primary sources 31
2.2.2.3 Key industry insights 32
2.2.2.4 Breakdown of primary interviews 32
2.3 MARKET SIZE ESTIMATION 33
2.3.1 BOTTOM-UP APPROACH 33
2.3.1.1 Approach 1: Company revenue estimation approach 34
2.3.1.2 Approach 2: Presentations of companies and primary interviews 34
2.3.1.3 Growth forecast 34
2.3.1.4 CAGR projections 35
2.3.2 TOP-DOWN APPROACH 35
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 36
2.5 MARKET SHARE ASSESSMENT 37
2.6 RESEARCH ASSUMPTIONS 38
2.6.1 PARAMETRIC ASSUMPTIONS 38
2.6.2 GROWTH RATE ASSUMPTIONS 38
2.7 RESEARCH LIMITATIONS 39
2.8 RISK ASSESSMENT 39
3 EXECUTIVE SUMMARY 40
 
4 PREMIUM INSIGHTS 44
4.1 BUNION SURGERY MARKET OVERVIEW 44
4.2 BUNION SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 44
4.3 BUNION SURGERY MARKET, BY PATIENT TYPE, 2024 VS. 2029 45
4.4 BUNION SURGERY MARKET, BY TYPE, 2024 VS. 2029 45
4.5 BUNION SURGERY MARKET, BY END USER, 2024 VS. 2029 46
4.6 BUNION SURGERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
5.2.1 DRIVERS 48
5.2.1.1 Increasing burden of bunion surgeries 48
5.2.1.2 Expanding geriatric population 48
5.2.1.3 Rising incidence of sports injuries and rheumatoid arthritis 49
5.2.1.4 Growing demand for minimally invasive surgeries 49
5.2.1.5 Increasing research funding and grants 50
5.2.2 RESTRAINTS 50
5.2.2.1 High cost of surgeries 50
5.2.3 OPPORTUNITIES 50
5.2.3.1 Rising number of hospitals and surgical centers worldwide 50
5.2.3.2 Growth opportunities in emerging markets 51
5.2.4 CHALLENGES 52
5.2.4.1 Availability of non-surgical alternatives 52
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 52
5.4 PRICING ANALYSIS 53
5.4.1 AVERAGE SELLING PRICE TREND OF BUNION SURGERY PRODUCTS 53
5.4.2 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY REGION 53
5.4.3 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS,
BY KEY PLAYER 54
5.5 VALUE CHAIN ANALYSIS 54
5.6 SUPPLY CHAIN ANALYSIS 56
5.7 ECOSYSTEM ANALYSIS 57
5.8 INVESTMENT AND FUNDING SCENARIO 58
5.9 TECHNOLOGY ANALYSIS 59
5.9.1 KEY TECHNOLOGIES 59
5.9.1.1 Implants 59
5.9.2 COMPLEMENTARY TECHNOLOGIES 59
5.9.2.1 Correction systems 59
5.9.3 ADJACENT TECHNOLOGIES 59
5.9.3.1 Splints 59
5.10 PATENT ANALYSIS 60
5.11 TRADE ANALYSIS 62
5.11.1 IMPORT DATA FOR HS CODE 9021 62
5.11.2 EXPORT DATA FOR HS CODE 9021 62
5.12 KEY CONFERENCES AND EVENTS, 2025–2026 63
5.13 REGULATORY LANDSCAPE 64
5.13.1 REGULATORY ANALYSIS 64
5.13.1.1 North America 64
5.13.1.1.1 US 64
5.13.1.1.2 Canada 66
5.13.1.2 Europe 67
5.13.1.3 Asia Pacific 68
5.13.1.3.1 China 68
5.13.1.3.2 Japan 69
5.13.1.3.3 India 70
5.13.1.4 Latin America 70
5.13.1.4.1 Brazil 70
5.13.1.4.2 Mexico 70
5.13.1.5 Middle East & Africa 71
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
5.14 PORTER’S FIVE FORCES ANALYSIS 74
5.14.1 THREAT OF NEW ENTRANTS 75
5.14.2 THREAT OF SUBSTITUTES 75
5.14.3 BARGAINING POWER OF BUYERS 75
5.14.4 BARGAINING POWER OF SUPPLIERS 75
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 75
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 75
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
5.15.2 BUYING CRITERIA 76
5.16 IMPACT OF AI ON BUNION SURGERY MARKET 77
5.16.1 INTRODUCTION 77
5.16.2 MARKET POTENTIAL OF AI 77
5.16.3 AI USE CASES 78
5.16.4 FUTURE OF AI/GEN AI 79
6 BUNION SURGERY MARKET, BY PRODUCT 80
6.1 INTRODUCTION 81
6.2 IMPLANTS & ACCESSORIES 81
6.2.1 SHIFTING DEMOGRAPHIC PATTERN TO FACILITATE GROWTH 81
6.3 CORRECTION SYSTEMS 84
6.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
TO DRIVE MARKET 84
7 BUNION SURGERY MARKET, BY PATIENT TYPE 88
7.1 INTRODUCTION 89
7.2 ADULT PATIENTS 89
7.2.1 CHANGING LIFESTYLE PREFERENCES TO PROMOTE GROWTH 89
7.3 PEDIATRIC PATIENTS 92
7.3.1 INCREASING PREVALENCE OF FLAT FEET AND CEREBRAL PALSY
TO AID GROWTH 92
8 BUNION SURGERY MARKET, BY TYPE 95
8.1 INTRODUCTION 96
8.2 TRADITIONAL SURGERIES 96
8.2.1 RISING POOL OF ARTHRITIS PATIENTS TO EXPEDITE GROWTH 96
8.3 MINIMALLY INVASIVE SURGERIES 99
8.3.1 GROWING ADVANCEMENTS IN SPECIALIZED SURGICAL TOOLS
TO FUEL MARKET 99
9 BUNION SURGERY MARKET, BY END USER 103
9.1 INTRODUCTION 104
9.2 HOSPITALS 104
9.2.1 INCREASING DEMAND FOR SPECIALIZED TREATMENTS TO SUSTAIN GROWTH 104
9.3 AMBULATORY SURGERY CENTERS 107
9.3.1 RISING INCLINATION TOWARD LOWER COSTS AND SHORTER PATIENT STAYS TO STIMULATE GROWTH 107
9.4 ORTHOPEDIC CLINICS 109
9.4.1 GROWING PREFERENCE FOR EFFECTIVE POST-OPERATIVE CARE AND LIMITED HOSPITALIZATION TO BOOST MARKET 109
10 BUNION SURGERY MARKET, BY REGION 113
10.1 INTRODUCTION 114
10.2 NORTH AMERICA 114
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 118
10.2.2 US 118
10.2.2.1 Increasing number of FDA approvals to facilitate growth 118
10.2.3 CANADA 120
10.2.3.1 Growing incidence of arthritis to promote growth 120
10.3 EUROPE 122
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 124
10.3.2 GERMANY 125
10.3.2.1 Increasing incidence of osteoporosis to expedite growth 125
10.3.3 UK 127
10.3.3.1 Growing demand for surgical treatments to drive market 127
10.3.4 FRANCE 129
10.3.4.1 Presence of robust healthcare system to augment growth 129
10.3.5 ITALY 131
10.3.5.1 Growing geriatric population to fuel market 131
10.3.6 SPAIN 132
10.3.6.1 Rising prevalence of hallux valgus to encourage growth 132
10.3.7 REST OF EUROPE 134
10.4 ASIA PACIFIC 136
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 139
10.4.2 CHINA 140
10.4.2.1 Growing public access to modern healthcare to fuel market growth 140
10.4.3 JAPAN 142
10.4.3.1 Rise in elderly population to support growth 142
10.4.4 INDIA 144
10.4.4.1 High prevalence of arthritis and foot deformities to encourage growth 144
10.4.5 REST OF ASIA PACIFIC 145
10.5 LATIN AMERICA 147
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 150
10.5.2 BRAZIL 151
10.5.2.1 Growing cultural focus on appearance to propel market 151
10.5.3 MEXICO 153
10.5.3.1 Increased availability of advanced surgical techniques to
augment growth 153
10.5.4 REST OF LATIN AMERICA 155
10.6 MIDDLE EAST & AFRICA 156
10.6.1 GROWING ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO PROPEL MARKET 156
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 158
10.7 GCC COUNTRIES 159
10.7.1 RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET 159
10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 161
11 COMPETITIVE LANDSCAPE 162
11.1 INTRODUCTION 162
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 162
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
BUNION SURGERY MARKET 162
11.3 REVENUE ANALYSIS, 2021–2023 164
11.4 MARKET SHARE ANALYSIS, 2023 165
11.5 COMPANY VALUATION AND FINANCIAL METRICS 167
11.6 BRAND/PRODUCT COMPARISON 168
11.6.1 SMITH+NEPHEW 168
11.6.2 ZIMMER BIOMET 168
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 169
11.7.1 STARS 169
11.7.2 EMERGING LEADERS 169
11.7.3 PERVASIVE PLAYERS 169
11.7.4 PARTICIPANTS 169
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 171
11.7.5.1 Company footprint 171
11.7.5.2 Region footprint 172
11.7.5.3 Product footprint 173
11.7.5.4 Patient type footprint 173
11.7.5.5 Type footprint 174
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 174
11.8.1 PROGRESSIVE COMPANIES 174
11.8.2 RESPONSIVE COMPANIES 174
11.8.3 DYNAMIC COMPANIES 174
11.8.4 STARTING BLOCKS 175
11.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023 176
11.8.5.1 Detailed list of key startups/SMEs 176
11.8.5.2 Competitive benchmarking of startups/SMEs 176
11.9 COMPETITIVE SCENARIO 177
11.9.1 PRODUCT LAUNCHES 177
11.9.2 DEALS 178
12 COMPANY PROFILES 179
12.1 KEY PLAYERS 179
12.1.1 STRYKER 179
12.1.1.1 Business overview 179
12.1.1.2 Products offered 180
12.1.1.3 Recent developments 182
12.1.1.3.1 Product launches 182
12.1.1.3.2 Deals 182
12.1.1.3.3 Expansions 182
12.1.1.3.4 Other developments 183
12.1.1.4 MnM view 183
12.1.1.4.1 Right to win 183
12.1.1.4.2 Strategic choices 183
12.1.1.4.3 Weaknesses and competitive threats 183
12.1.2 ZIMMER BIOMET 184
12.1.2.1 Business overview 184
12.1.2.2 Products offered 185
12.1.2.2.1 Deals 186
12.1.2.3 MnM view 186
12.1.2.3.1 Right to win 186
12.1.2.3.2 Strategic choices 186
12.1.2.3.3 Weaknesses and competitive threats 187
12.1.3 JOHNSON & JOHNSON SERVICES, INC. 188
12.1.3.1 Business overview 188
12.1.3.2 Products offered 189
12.1.3.3 Recent developments 190
12.1.3.3.1 Product launches 190
12.1.3.3.2 Deals 190
12.1.3.4 MnM view 190
12.1.3.4.1 Right to win 190
12.1.3.4.2 Strategic choices 191
12.1.3.4.3 Weaknesses and competitive threats 191
12.1.4 SMITH+NEPHEW 192
12.1.4.1 Business overview 192
12.1.4.2 Products offered 193
12.1.4.3 Recent developments 194
12.1.4.3.1 Deals 194
12.1.4.4 MnM view 194
12.1.4.4.1 Right to win 194
12.1.4.4.2 Strategic choices 194
12.1.4.4.3 Weaknesses and competitive threats 194
12.1.5 ENOVIS CORPORATION 195
12.1.5.1 Business overview 195
12.1.5.2 Products offered 196
12.1.5.3 Recent developments 197
12.1.5.3.1 Deals 197
12.1.5.3.2 Expansions 197
12.1.6 PARAGON 28, INC. 198
12.1.6.1 Business overview 198
12.1.6.2 Products offered 199
12.1.6.3 Recent developments 201
12.1.6.3.1 Product launches 201
12.1.6.3.2 Deals 201
12.1.6.4 MnM view 202
12.1.6.4.1 Right to win 202
12.1.6.4.2 Strategic choices 202
12.1.6.4.3 Weaknesses and competitive threats 202
12.1.7 TREACE MEDICAL CONCEPTS, INC. 203
12.1.7.1 Business overview 203
12.1.7.2 Products offered 204
12.1.7.3 Recent developments 205
12.1.7.3.1 Product launches 205
12.1.7.3.2 Deals 205
12.1.7.3.3 Other developments 206
12.1.8 CONMED CORPORATION 207
12.1.8.1 Business overview 207
12.1.8.2 Products offered 208
12.1.9 MEDARTIS AG 209
12.1.9.1 Business overview 209
12.1.9.2 Products offered 210
12.1.9.3 Recent developments 211
12.1.9.3.1 Product launches 211
12.1.9.3.2 Deals 211
12.1.10 DOUBLE MEDICAL TECHNOLOGY INC. 212
12.1.10.1 Business overview 212
12.1.10.2 Products offered 212
12.1.11 ARTHREX, INC. 213
12.1.11.1 Business overview 213
12.1.11.2 Products offered 213
12.1.11.3 Recent developments 214
12.1.11.3.1 Product launches 214
12.1.12 ACUMED LLC 215
12.1.12.1 Business overview 215
12.1.12.2 Products offered 215
12.1.12.3 Recent developments 216
12.1.12.3.1 Expansions 216
12.1.13 MERETE GMBH 217
12.1.13.1 Business overview 217
12.1.13.2 Products offered 217
12.1.14 VOOM MEDICAL DEVICES 218
12.1.14.1 Business overview 218
12.1.14.2 Products offered 218
12.1.15 BIOPRO, INC 219
12.1.15.1 Business overview 219
12.1.15.2 Products offered 219
12.2 OTHER PLAYERS 220
12.2.1 DIETER MARQUARDT MEDIZINTECHNIK GMBH 220
12.2.2 EXTREMITY MEDICAL 221
12.2.3 ASTROLABE 221
12.2.4 INVAMED 222
12.2.5 ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES 222
12.2.6 AUXEIN 223
12.2.7 EXACTECH, INC. 223
12.2.8 JEIL MEDICAL CORPORATION 224
12.2.9 AYSAM ORTHOPAEDICS & MEDICAL DEVICES 224
12.2.10 DEVA TIBBI MALZEMELER 225
13 APPENDIX 226
13.1 DISCUSSION GUIDE 226
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 230
13.3 CUSTOMIZATION OPTIONS 232
13.4 RELATED REPORTS 232
13.5 AUTHOR DETAILS 233